Is the upper shoulder region highly vascular in a patient with a history of seizures following lidocaine (local anesthetic) injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is the Upper Shoulder Highly Vascular?

Yes, the upper shoulder region is highly vascular, containing major vessels including the subclavian artery and vein, and this vascularity creates significant risk for inadvertent intravascular injection of local anesthetics like lidocaine, which can cause immediate seizures if the drug enters the bloodstream directly.

Vascular Anatomy of the Upper Shoulder

The upper shoulder region contains critical large-caliber vessels that make it a highly vascular area:

  • The subclavian vein and artery traverse the upper shoulder region, representing major central vessels with high blood flow that can rapidly distribute injected medications systemically 1.

  • Inadvertent arterial puncture during procedures in this region carries significant hemorrhagic risk, as evidenced by guidelines recommending that insertion sites allowing easy vessel compression be chosen when coagulopathy is present, with femoral access sometimes preferred over subclavian approaches 1.

  • The Association of Anaesthetists guidelines specifically note that bleeding risks vary with anatomical site, with the subclavian region having higher complication rates including pneumothorax (0.3-2.3%, highest with subclavian route) and hemothorax from vascular trauma 1.

Clinical Significance for Lidocaine Injections

The high vascularity of the upper shoulder creates specific risks when administering local anesthetics:

  • Inadvertent intravascular injection of lidocaine causes immediate seizures through direct systemic absorption, as documented in multiple case reports where seizures occurred "immediately after injection" or "shortly after" lidocaine administration 2, 3.

  • Lidocaine concentrations above 15 μg/mL frequently result in seizures in both laboratory animals and humans, and intravascular injection bypasses normal tissue absorption, delivering toxic concentrations directly to the central nervous system 4, 5.

  • Seizures from lidocaine toxicity are almost invariably generalized tonic-clonic seizures without focal features, despite experimental models showing focal amygdala onset, suggesting rapid systemic distribution when vascular injection occurs 4.

Risk Mitigation Strategies

Given the high vascularity of the upper shoulder region:

  • Always aspirate before injecting lidocaine to detect intravascular needle placement, as the presence of blood return indicates vascular puncture requiring needle repositioning 1.

  • Use ultrasound guidance with color Doppler to visualize vascular structures before needle insertion in the upper shoulder region, as this significantly reduces the risk of vascular puncture 1.

  • Administer lidocaine slowly in divided doses rather than as a single bolus, as this allows early detection of systemic toxicity symptoms (perioral numbness, tinnitus, altered mental status) before full toxic dose is delivered 1.

  • Have immediate seizure management capabilities available, including IV benzodiazepines (lorazepam 0.1 mg/kg IV, maximum 4 mg at 2 mg/min) and airway equipment, whenever performing injections in highly vascular regions like the upper shoulder 6, 7.

Common Pitfalls

  • Assuming that aspiration alone is sufficient: Even with negative aspiration, the needle tip may migrate into a vessel during injection, so slow incremental injection with frequent re-aspiration is essential 1.

  • Underestimating the speed of systemic absorption: In highly vascular areas like the upper shoulder, intravascular injection causes seizures within seconds to minutes, not the 30+ minutes typical of tissue absorption 2, 3.

  • Failing to recognize that a history of seizures is NOT a contraindication to lidocaine use: The evidence shows that partial seizure history does not increase risk of lidocaine-induced seizures, as these are generalized and concentration-dependent rather than related to underlying seizure disorders 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lidocaine and seizures.

Therapeutic drug monitoring, 2000

Research

Recurrent seizures after lidocaine ingestion.

Journal of advanced pharmaceutical technology & research, 2015

Guideline

Management of Seizure-Like Activity with Right Parietal Hypodensities and Dilated Perivascular Spaces

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Generalized Tonic-Clonic Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.